Publicly traded cannabis company MedMen has had a turbulent year, having had to deal with management shakeups, the ousting of its co-founders and lawsuits. And, although the stock is still up about 16% year-to-date, it has fallen considerably from the $1.29 per share value it reached in February – it’s now under $0.20.
But some good news could give the company a much needed boost in the capital markets: According to information procured exclusively, MedMen will be opening its newest store in Boston’s famed Fenway Park area.
The 4,725 square-feet MedMen Fenway dispensary will be located on 120 Brookline Avenue and opens this Wednesday. This is the company’s first entry into Massachusetts’ booming adult-use market.
“As we continue to execute against our aggressive growth plans as MedMen 2.0, we are excited to announce the opening of our newest location in the very heart and soul of Boston,” said Michael Serruya, interim CEO, MedMen. “We look forward to becoming a contributing member of the vibrant Fenway Park community and to serving the Greater Boston area with best-in-class cannabis products and exceptional customer service.”
The Good Stuff
MedMen Fenway will carry a full inventory of vaporizers, concentrates,